Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2021 Mar 8;19:100. doi: 10.1186/s12967-021-02746-0

Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome

Mathieu Blot 1,2,, Jean-Baptiste Bour 3, Jean Pierre Quenot 2,4,5,6, Abderrahmane Bourredjem 5,6, Maxime Nguyen 2,7, Julien Guy 8, Serge Monier 2,9, Marjolaine Georges 10, Audrey Large 4, Auguste Dargent 2,4, Alexandre Guilhem 11, Suzanne Mouries-Martin 12, Jeremy Barben 13, Belaid Bouhemad 2,7, Pierre‑Emmanuel Charles 2,4, Pascal Chavanet 1,5,6, Christine Binquet 2,5,6, Lionel Piroth 1,5,6; for the LYMPHONIE Study Group
PMCID: PMC7938689  PMID: 33685465

Correction to: J Transl Medi (2020) 18:457 10.1186/s12967-020-02646-9

Following publication of the original article [1], the authors identified an error in the author group. The investigators of the Lymphonie study group weren’t tagged as collaborators. figure are published in this Correction article. The original article has been updated.

The collaborators’ names are included in the ‘Acknowledgements’ section and listed below. The author group has been updated above and the original article [1] has been corrected.

The investigators of the LYMPHONIE study group are:

Pascal Andreu, François Aptel, Marie Labruyère, Sébastien Prin, Guillaume Beltramo, Philippe Bonniaud, Philip Bielefeld, Hervé Devilliers, Bernard Bonnotte, Marielle Buisson and Alain Putot.

The publisher apologises to the authors and the readers for the inconvenience caused by this error.

Acknowledgements

The authors thank all the investigators of the Lymphonie study group (Pascal Andreu, François Aptel, Marie Labruyère, Sébastien Prin (Department of Intensive Care, Dijon Bourgogne University Hospital, Dijon, France); Guillaume Beltramo, Philippe Bonniaud (Department of Pneumology, Dijon Bourgogne University Hospital, Dijon, France); Philip Bielefeld, Hervé Devilliers (Department of Internal Medicine and Systemic Diseases, Dijon Bourgogne University Hospital, Dijon, France); Bernard Bonnotte (Department of Internal Medicine and Clinical Immunology, Dijon Bourgogne University Hospital, Dijon, France); Marielle Buisson (Infectious Diseases Department, Dijon Bourgogne University Hospital, Dijon, France); Alain Putot (Geriatrics Internal Medicine Department, Dijon Bourgogne University Hospital, Dijon, France). We thank the CIC-EC1432 (Alexandra Lamotte-Felin, Lydie Rossie and Delphine Pecqueur), the Intensive Care Medicine Research team (Solenne Villot, Mathilde Audry and Samantha Lima), the Cytometry core facility, Berengere Grammatico from the laboratory of virology and Shaliha Bechoua from the CRB (Centre de Ressource Biologique)). We also thank all the donors (crowdfunding; https://thellie.org/covid-19), and the patients and healthcare team. We thank Fiona Ecarnot, PhD (EA3920, University of Burgundy Franche-Comté, Besançon, France) for proofreading and editing the manuscript.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Mathieu Blot, Email: mathieu.blot@chu-dijon.fr.

for the LYMPHONIE Study Group:

Pascal Andreu, François Aptel, Marie Labruyère, Sébastien Prin, Guillaume Beltramo, Philippe Bonniaud, Philip Bielefeld, Hervé Devilliers, Bernard Bonnotte, Marielle Buisson, and Alain Putot

Reference

  • 1.Blot M, Bour J-P, Quenot JP, Bourredjem A, Nguyen M, Guy J, Monier S, Georges M, Large A, Dargent A, Guilhem A, Mouries-Martin S, Barben J, Bouhemad B, Charles P-E, Chavanet P, Binquet C, Piroth L, the LYMPHONIE Study Group The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. J Transl Med. 2020;18:457. doi: 10.1186/s12967-020-02646-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES